Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.
Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment has changed everything.
New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.
The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.
Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.
A minority veterans organization wants access to psychedelic therapies for PTSD and depression. It’s urging Congress to take action.
Hey guys! Today’s episode is more of a fast rant on the recent press release about MindMed raising ANOTHER $19.5M from Canaccord Genuity Corp, on a deal that is set to close tomorrow, March 9th.
Here, I’m discussing:
1. The number MindMed shares being sold and their respective price;
2.Why is MindMed doing this?
3. Potential short term and long term effects on MMED’s stock price
4. Nasdaq uplisting?
5. Market crash thoughts
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #MMEDNews
MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.